These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer. Chung HH; Kim JW; Park NH; Song YS; Kang SB; Lee HP Acta Obstet Gynecol Scand; 2006; 85(12):1501-5. PubMed ID: 17260229 [TBL] [Abstract][Full Text] [Related]
3. TATI (tumor associated trypsin inhibitor) and cancer antigen 125 (CA 125) in patients with early-stage endometrial cancer. Peters-Engl C; Buxbaum P; Ogris E; Sevelda P; Medl M Anticancer Res; 1998; 18(6B):4635-9. PubMed ID: 9891532 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of preoperative criteria used to predict lymph node metastasis in endometrial cancer. Han SS; Lee SH; Kim DH; Kim JW; Park NH; Kang SB; Song YS Acta Obstet Gynecol Scand; 2010; 89(2):168-74. PubMed ID: 19916890 [TBL] [Abstract][Full Text] [Related]
5. Preoperative serum CA 125 level in the prediction of the stage of disease in endometrial carcinoma. Yildiz A; Yetimalar H; Kasap B; Aydin C; Tatar S; Soylu F; Yildiz FS Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):191-5. PubMed ID: 22727919 [TBL] [Abstract][Full Text] [Related]
6. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer. Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB Acta Obstet Gynecol Scand; 2008; 87(11):1136-42. PubMed ID: 18951217 [TBL] [Abstract][Full Text] [Related]
7. Predictors of final histology in patients with endometrial cancer. Frumovitz M; Singh DK; Meyer L; Smith DH; Wertheim I; Resnik E; Bodurka DC Gynecol Oncol; 2004 Dec; 95(3):463-8. PubMed ID: 15581947 [TBL] [Abstract][Full Text] [Related]
8. Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer. Chen YL; Huang CY; Chien TY; Huang SH; Wu CJ; Ho CM Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):397-402. PubMed ID: 21806586 [TBL] [Abstract][Full Text] [Related]
9. Preoperative identification of a low-risk group for lymph node metastasis in endometrial cancer: a Korean gynecologic oncology group study. Kang S; Kang WD; Chung HH; Jeong DH; Seo SS; Lee JM; Lee JK; Kim JW; Kim SM; Park SY; Kim KT J Clin Oncol; 2012 Apr; 30(12):1329-34. PubMed ID: 22412131 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the sensitivity, specificity, positive and negative predictive values of preoperative magnetic resonance imaging for staging endometrial cancer. A prospective study of 100 cases at the Dorset Cancer Centre. Ortashi O; Jain S; Emannuel O; Henry R; Wood A; Evans J Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):232-5. PubMed ID: 17537566 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: a multi-center study. Kim HS; Park CY; Lee JM; Lee JK; Cho CH; Kim SM; Kim JW Gynecol Oncol; 2010 Sep; 118(3):283-8. PubMed ID: 20541245 [TBL] [Abstract][Full Text] [Related]
12. [Preoperative platelet count as index of the grading in endometrial carcinoma]. Giannella L; Menozzi G; Di Monte I; Venturini P; De Pace V; Boselli F; Ternelli G; Jasonni VM Minerva Ginecol; 2008 Aug; 60(4):273-9. PubMed ID: 18560341 [TBL] [Abstract][Full Text] [Related]
13. Peritoneal cytology and preoperative serum CA 125 level are important prognostic indicators of overall survival in advanced endometrial cancer. Santala M; Talvensaari-Mattila A; Kauppila A Anticancer Res; 2003; 23(3C):3097-103. PubMed ID: 12926169 [TBL] [Abstract][Full Text] [Related]
14. The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma. Ayhan A; Bozdag G; Taskiran C; Gultekin M; Yuce K; Kucukali T Gynecol Oncol; 2006 Dec; 103(3):902-5. PubMed ID: 16828847 [TBL] [Abstract][Full Text] [Related]
15. Serum CA 125 measurements to identify patients with endometrial cancer who require lymphadenectomy. Koper NP; Massuger LF; Thomas CM; Kiemeney LA; Verbeek AL Anticancer Res; 1998; 18(3B):1897-902. PubMed ID: 9677441 [TBL] [Abstract][Full Text] [Related]
16. Feasibility of routine lymphadenectomy in clinical stage-I endometrial cancer. Han SS; Cho JY; Park IA; Park SK; Jeon YT; Kim JW; Park NH; Kang SB; Lee HP; Song YS Med Sci Monit; 2008 Apr; 14(4):CR183-9. PubMed ID: 18376345 [TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma. Schwab KV; O'Malley DM; Fowler JM; Copeland LJ; Cohn DE Gynecol Oncol; 2009 Jan; 112(1):146-9. PubMed ID: 18937970 [TBL] [Abstract][Full Text] [Related]
18. A retrospective study of preoperative CA 125 levels in 82 patients with ovarian cancer. Rossi AC; Di Vagno G; Cormio G; Cazzolla A; Stefanelli S; D'Elia E; Selvaggi L Arch Gynecol Obstet; 2004 May; 269(4):263-5. PubMed ID: 14745561 [TBL] [Abstract][Full Text] [Related]
19. HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET). Antonsen SL; Høgdall E; Christensen IJ; Lydolph M; Tabor A; Loft Jakobsen A; Fagö-Olsen CL; Andersen ES; Jochumsen K; Høgdall C Acta Obstet Gynecol Scand; 2013 Nov; 92(11):1313-22. PubMed ID: 24032654 [TBL] [Abstract][Full Text] [Related]
20. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases. Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]